Maddy’s LenseCraft

[maddyslensecraft]

Value-Based Care Drives a New Wave of Growth for Healthcare Consulting Services

The global healthcare consulting services market is set for strong expansion, projected to grow from USD 32.2 billion in 2025 to USD 52.0 billion by 2030, registering a CAGR of 10.1% over the forecast period. This growth is fueled by increasing complexity across healthcare systems, evolving regulatory frameworks, and accelerating transitions toward value-based care models, prompting providers, payers, and life sciences organizations to rely on expert consulting partners to navigate operational, technological, and financial challenges.

Healthcare organizations across the globe are grappling with rising care costs, workforce shortages, digital transformation pressures, and the need to deliver patient-centric, efficient care. These challenges are encouraging hospitals, insurance payers, pharmaceutical manufacturers, and MedTech companies to outsource strategic management, digital modernization, compliance, and process optimization initiatives to specialized consulting firms.

North America Leads; Strategy Consulting Dominates

North America continued to be the largest regional market in 2024, capturing 45.6% of total global revenues, supported by advanced healthcare infrastructure, strong adoption of health IT, and ongoing regulatory reforms. Strategy consulting emerged as the leading service category, accounting for 30.3% of the global market share, reflecting strong demand for organizational transformation and long-term planning.

Healthcare providers - including hospitals, clinics, and integrated health systems—represent the fastest-growing end-user segment and are expected to expand at 11.2% CAGR through 2030, driven by increasing consulting needs across digital transformation, clinical workflow optimization, financial restructuring, and regulatory compliance.

Download PDF Brochure - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41882774

Industry Leaders and Emerging Innovators Gain Momentum

Leading global firms such as Accenture, Deloitte, and Cognizant have been identified as star performers due to their strong market presence, breadth of services, and advanced digital health capabilities. These firms are supporting large-scale transformations involving cloud migration, AI-powered analytics, enterprise-wide interoperability, and patient engagement advancements.

Meanwhile, emerging players—including Blue Matter Consulting, ISOS Consulting Services Pvt. Ltd., Lucid Health Consulting, and Quality Crest Healthcare Consultants—are gaining traction by establishing strong footholds in specialized niches such as life sciences strategy, compliance services, and healthcare quality consulting. Their agility and domain expertise position them as promising future leaders in targeted market segments.

Key Market Drivers and Opportunities

The widespread adoption of big data analytics, IoT, cloud platforms, AI-driven diagnostics, telemedicine, and EHRs continues to significantly increase the demand for consulting services. Government support for healthcare IT modernization further accelerates the market.

Growing opportunities in emerging markets, combined with a steady rise in mergers and acquisitions, are creating substantial consulting demand across integration planning, restructuring, regulatory alignment, and operational transformation. However, concerns around data confidentiality, rising consulting costs, and the complexity of multi-sourcing models remain key challenges.

Consulting Use Cases Transforming Healthcare

Leading consulting firms are driving tangible improvements across the healthcare ecosystem:

- Accenture enables digital transformation with advanced analytics, cloud modernization, and patient engagement platforms, helping clients optimize processes, reduce costs, and improve outcomes. - Cognizant deploys AI-enabled population health management solutions that integrate clinical, claims, and social determinants data to reduce readmission rates and enhance preventive care. - Deloitte supports enterprise interoperability and data governance frameworks that enhance regulatory compliance, care coordination, and clinical decision-making. - McKinsey & Company builds predictive analytics and AI-led operational models that improve workforce productivity and hospital resource management. - Boston Consulting Group (BCG) guides organizations in scaling virtual care and telemedicine models, expanding access to care and improving patient experience.

Recent Industry Developments

Notable advancements include the December 2024 Accenture–HCG partnership to deploy AI-driven oncology solutions in South Asia; PwC India's collaboration with Automation Anywhere in November 2024 to accelerate generative AI automation in healthcare; and Accenture’s October 2024 acquisition of consus.health, strengthening digital transformation capabilities across Europe.

Request Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=41882774

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: [phone] Email: [email protected]

[maddyslensecraft]

Healthcare IT Market Growth Accelerates as Value-Based Care and Real-World Evidence Adoption Strengthen

Global Healthcare IT Market to Reach US$834.35 Billion by 2029 Amid Accelerated Digital Transformation

The global Healthcare IT market continues to expand rapidly, rising from US$368.15 billion in 2023 to US$420.23 billion in 2024, and projected to reach US$834.35 billion by 2029 at a CAGR of 14.7 percent. Growth is driven by technological advancements, increased telehealth adoption, and rising use of user-generated digital health data. The shift toward patient-centered, value-based care and the growing use of Real-World Evidence (RWE) are further strengthening demand for digital health solutions. However, data governance limitations, lack of standardized frameworks, and increasing concerns around patient consent remain notable challenges.

Regional and Market Highlights - Asia Pacific is emerging as a high-growth region due to rising HCIT spending, large patient populations, and expanding use of big data in healthcare. - Europe is experiencing strong momentum with growing adoption of telehealth and increased integration of big data. - North America currently holds the largest market share, supported by widespread EHR implementation, interoperability initiatives, and strategic digital investments.

Key Forces Shaping the Market

Drivers Government initiatives, including the Federal Health IT Strategic Plan (2024–2030) in the US, continue to accelerate the adoption of healthcare IT solutions. Countries such as Saudi Arabia are also advancing digital healthcare through significant national investments.

Restraints Rising cybersecurity risks and data breach concerns are impacting the pace of HCIT adoption.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252

Opportunities The rapidly increasing volume of healthcare data, with hospitals generating up to 50 petabytes annually, is driving strong demand for analytics, cloud platforms, and interoperable data systems.

Challenges A shortage of skilled healthcare and IT professionals is affecting the speed and effectiveness of digital transformation across the industry.

Ecosystem and Competitive Landscape

The healthcare IT market includes solution providers, regulatory authorities, and healthcare organizations. Key companies include Optum, Cognizant, Philips, Oracle, GE Healthcare, Wipro, eClinicalWorks, Epic Systems, InterSystems, and several others. Recent developments involve AI-driven products, cloud platform advancements, and strategic collaborations led by companies such as Royal Philips, GE Healthcare, Optum, Wipro, and eClinicalWorks.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA : 1-888-600-6441 [email protected]

[maddyslensecraft]

Pharmaceutical Drug Delivery Market Outlook: Growth Drivers and Industry Dynamics

The global pharmaceutical drug delivery market is experiencing sustained expansion, driven by rising chronic disease prevalence, growing geriatric populations, technological innovation, and increasing demand for patient-centric care. The market, valued at US$1,831.1 million in 2023, increased to US$1,949.4 million in 2024 and is projected to reach US$2,546.0 million by 2029, registering a 5.5% CAGR over the forecast period.

Key Market Drivers:

Growing Chronic Disease Burden: Increasing cases of diabetes, hypertension, cancer, and infectious diseases are accelerating demand for advanced drug delivery solutions. Rising Geriatric Population: Higher susceptibility to chronic illnesses is boosting the need for efficient and accessible delivery methods. R&D Investments & Product Innovation: Manufacturers are modernizing technologies to improve efficiency, safety, and compliance. Patient Comfort & Home-Based Care: A rising preference for self-administration and home care is strengthening adoption of user-friendly delivery devices. Supportive Government Initiatives: Programs promoting affordability and access to healthcare continue to support market expansion.

Market Challenges

Needlestick Injury Risks: Persistent concern around occupational injuries associated with injectables influences adoption. Global Pricing Pressures: Regulatory and insurer-driven price caps are constraining revenue potential for manufacturers.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1085

Segment Insights

Injectable Drug Delivery Leads the Market Injectables remain the dominant segment due to their effectiveness in managing complex and chronic diseases. Advances in autoinjectors, cartridges, pen injectors, and needle technologies are enhancing usability and supporting the shift toward self-administration.

Hospitals Show Strong Growth

Hospitals continue to expand their share due to high patient volumes, increased surgeries, improved infusion systems, and a rising emphasis on medication accuracy and safety.

Regional Highlights: Asia Pacific region holds the largest share North America is anticipated to represent the largest regional market during the forecast period. The regional market, comprising the US and Canada, shows high demand for drug delivery technologies. This is mainly due to the availability of favorable reimbursement options, growing awareness of new technologies, favorable government initiatives, the growing affordability & per capita healthcare expenditure, the presence of many global pharmaceutical giants (such as Pfizer and Johnson & Johnson), and the patent expiry of blockbuster drugs during 2019–2025.

Recent Industry Developments:

March 2024: Johnson & Johnson acquired Ambrx Biopharma to strengthen its portfolio of next-generation antibody-drug conjugates. January 2024: AbbVie expanded its biologics manufacturing capacity in Singapore with a USD 223 million investment.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=1085

Key Market Participants:

Johnson & Johnson Services, Novartis AG, F. Hoffmann-La Roche, Pfizer, Becton, Dickinson and Company, GlaxoSmithKline, Merck & Co., Sanofi, Bayer AG, Amgen, AbbVie, Genmab A/S, Gilead Sciences, Boehringer Ingelheim International, and AstraZeneca.

Research Methodology

This analysis is based on extensive primary and secondary research, including interviews with senior industry professionals and review of industry databases, company filings, government publications, and academic sources. Market sizing was determined through revenue mapping, top-down and bottom-up modeling, and data triangulation.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA : 1-888-600-6441 [email protected]

[maddyslensecraft]

Research Methodologies Followed in this Study - Primary Research - Extensive primary research was conducted after acquiring basic knowledg

Factors contributing to the growth of the global market include increasing R&D investments and funding in cell-based resaerch and growing emphasis on technological advancements. However, high cost of cell-based resaerch is expected to hinder market growth.

[maddyslensecraft]

Projected Surge in Global Revenue -

The growing developments in minimally invasive surgical techniques, like laparoscopy and arthroscopy, make surgery more attractive to pet owners, offering a faster recovery time and less pain for pets. However, veterinary surgery procedures may not only include the actual surgery but also pre- and post-operative care, medication, and sometimes even long-term management. This will likely provide a barrier for the owner, specifically when considering non-essential surgeries.

[maddyslensecraft]

Respiratory Care Devices Market - Emerging Trends by 2028

The global respiratory care devices market, valued at $21.8 billion in 2023, is projected to reach $31.8 billion by 2028, with a 7.8% CAGR d

The global respiratory care devices market in terms of revenue was estimated to be worth $21.8 billion in 2023 and is poised to reach $31.8 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028. Growth in this market is largely driven by the growth in the number of patients suffering from respiratory disorders, such as COPD and asthma, increase in overweight and obese population, and rising number of preterm births. Globally, the number of preterm births has increased over the past 20 years. Pregnancy at an inappropriate age, generally over 40 years and below 20 years, increases the risk of preterm delivery. Reasons for preterm births include maternal health problems, including diabetes, high blood pressure, and massive usage of infertility treatments.

[maddyslensecraft]

The animal parasiticides industry is expected to witness significant growth over the near future. This growth can be attributed to…

The animal parasiticides industry is expected to witness significant growth over the near future. This growth can be attributed to increasing awareness of pet health, increasing pet ownership, and the rising demand for pet health products. Increasing disposable incomes, the rising trend of pet humanization and an increasing number of pet owners are some of the major factors driving the growth of the pet parasiticides market. Furthermore, growing awareness of pet health and increasing awareness of parasitic diseases in pets is also expected to drive the growth of the pet parasiticides market. Additionally, technological advancements in pet parasiticides products, such as spot-on, sprays, and shampoos, are expected to fuel market growth over the near future.

[maddyslensecraft]

From $4.6B in 2022 to $5.8B by 2027: Future Growth Trends in Liquid Handling Systems Industry

Liquid Handling System is a device used to transport small liquid, such as biological samples, chemicals, or reagents, from one container to

Liquid Handling System Market in terms of revenue was estimated to be worth $4.6 billion in 2022 and is poised to reach $5.8 billion by 2027, growing at a CAGR of 4.6% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by industrial growth in the pharma-biotech sector, rising R&D expenditure by biotechnology and pharmaceutical industries, and increasing life science research, which is supported by a favorable funding scenario, expansion of pharmaceutical & biotechnology industries, increasing focus on data precision and accuracy and Increasing labor costs leading to higher automation requirements.

[maddyslensecraft]

The utilization of digital twins in the healthcare industry is expected to revolutionize patient care and enhance overall healthcare outcome

Digital Twins in Healthcare Market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $21.1 billion by 2028, growing at a CAGR of 67.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rise in investments & funding in the digital twin market supporting the growing number of startups and increasing focus on cutting-edge real-time analytics are some of the key factors that offer opportunities to the market during the forecast period. However, the obsolete digital infrastructure and the reluctance towards the use of new technologies are challenging the market growth to some extent.

[maddyslensecraft]

Drug Discovery Services Market worth $41.3 billion | MarketsandMarkets

The drug discovery services industry is expected to grow significantly in the near future, driven by advances in technology, increasing dema

The size of global drug discovery services market in terms of revenue was estimated to be worth $20.6 billion in 2023 and is poised to reach $41.3 billion by 2028, growing at a CAGR of 14.9% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

[maddyslensecraft]

Projected to grow at a CAGR of 10.5%, the global medical equipment maintenance market is anticipated to reach USD 88.9 billion by 2029, up f

Medical Equipment Maintenance Market: Forecasted USD 88.9 Billion by 2029, CAGR 10.5%

The size of global medical equipment maintenance market in terms of revenue was estimated to be worth $54.0 billion in 2024 and is poised to reach $88.9 billion by 2029, growing at a CAGR of 10.5% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

[maddyslensecraft]

Sleep Apnea Devices Market worth $8.0 billion | MarketsandMarkets

The sleep apnea devices industry is poised for significant growth and innovation in the near future. With increasing awareness about the det

The size of global sleep apnea devices market in terms of revenue was estimated to be worth $5.8 billion in 2023 and is poised to reach $8.0 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

[maddyslensecraft]

Pipette Calibrators Market Worth $391 million | MarketsandMarkets™

Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, g

Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.

The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical companies.

[maddyslensecraft]

The report “Brain Monitoring Market by Devices (EEG, EMG, MEG, ICP, MRI, fMRI, CT) Accessories (Electrode, Sensor), Modality (Portable…

The global brain monitoring market in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $4.8 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The propulsion of the brain monitoring market primarily stems from the escalating occurrence and prevalence of neurological disorders, heightened awareness surrounding neurodegenerative diseases, a surge in traumatic brain injuries, and the expanded utilization of brain monitoring in clinical trials. Additionally, the increasing need for non-invasive and minimally invasive devices, the broadening therapeutic applications of brain monitoring tools, and the expanding healthcare sector in emerging economies are anticipated to offer growth opportunities for market players.

[maddyslensecraft]

The Future of Medicine: Exploring the Pharmaceutical Drug Delivery Market’s Growth by 2026

The pharmaceutical drug delivery market is on the brink of a significant transformation. According to the recent report, “Pharmaceutical Dru

The size of global pharmaceutical drug delivery market in terms of revenue was estimated to be worth $1,656.9 billion in 2021 and is poised to reach $2,206.5 billion by 2026, growing at a CAGR of 5.9% from 2021 to 2026. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

[maddyslensecraft]

Growth Driving Factors:The healthcare cloud computing market is primarily driven by several key factors such as the growing adoption of EHR,

The healthcare cloud computing market is primarily driven by several key factors such as the growing adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions due to pandemic; the increasing use of big data analytics, wearable devices, and IoT; the rising deployment of cloud solutions in the healthcare industry; and the improved data storage, flexibility, and scalability offered by cloud computing. Additionally, the proliferation of new payment models and the cost-efficiency of cloud services, along with the dynamic nature of health benefit plan designs, further contribute to market growth. However, concerns regarding data security and the complexity of regulations governing cloud data centers are expected to restrain market growth to some extent.

[maddyslensecraft]

Healthcare Cloud Computing Market worth $120.6 billion by 2029

Growth Driving Factors:

The healthcare cloud computing market is primarily driven by several key factors such as the growing adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions due to pandemic; the increasing use of big data analytics, wearable devices, and IoT; the rising deployment of cloud solutions in the healthcare industry; and the improved data storage, flexibility, and scalability offered by cloud computing.

Additionally, the proliferation of new payment models and the cost-efficiency of cloud services, along with the dynamic nature of health benefit plan designs, further contribute to market growth. However, concerns regarding data security and the complexity of regulations governing cloud data centers are expected to restrain market growth to some extent.

Projected Surge in Global Revenue:

The size of global healthcare cloud computing market in terms of revenue was estimated to be worth $53.8 billion in 2024 and is poised to reach $120.6 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029.

Download PDF Brochure for More Details@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

“The largest share in the healthcare cloud computing market, based on product, was attributed to the healthcare providers segment in 2023.”

In 2023, the healthcare provider segment held a significant share of the healthcare cloud computing market, by product. This segment is projected to demonstrate the highest growth rate during the forecast period. The substantial share can be attributed to the increasing adoption of big data analytics and various healthcare IT solutions, driven by the impacts of the pandemic. Additionally, the shift towards value-based care and the increasing focus on patient outcomes drive healthcare providers to adopt cloud solutions that can support telemedicine, mobile health applications, and integrated care models. The necessity for compliance with stringent regulatory standards, such as HIPAA in the U.S., further accelerates the adoption of cloud technologies, as they offer built-in security and compliance features.

“By component, the services segment held the largest market share of healthcare cloud computing market in 2023.”

In 2023, the services segment held the largest share of the healthcare cloud computing market. This growth is driven by the introduction of complex software and the necessity to ensure integration and interoperability, which require extensive training and regular upgrades. Services such as consulting, implementation, ongoing IT support, training, and post-sales maintenance are essential for healthcare providers to effectively transition to and utilize cloud-based systems. These services help address the complex requirements of healthcare IT environments, ensuring seamless integration with existing systems, maintaining compliance with regulatory standards, and optimizing performance.

Geographical Growth Dynamics:

“North America accounted for the largest share of the healthcare cloud computing market in 2023.”

The healthcare cloud computing market is segmented into five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.

In 2023, North America held the largest share of the market, followed by Europe and the Asia Pacific. This dominance in North America can be attributed to several factors, including favorable government initiatives and high healthcare expenditure. Additionally, the presence of many healthcare cloud computing companies headquartered in the region contributes to its lucrative market environment.

The Asia Pacific region was the fastest-growing market, driven by the increasing adoption of digital health solutions, healthcare infrastructure reforms in China, the rapidly expanding healthcare industry in India, and the implementation of health IT programs in Australia and New Zealand.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=347

Key Market Players:

The key players functioning in the healthcare cloud computing market include Amazon Web Services, Inc. (US), Microsoft (US), Google, Inc. (US), athenahealth. Inc. (US), CareCloud, Inc. (US), Siemens Healthineers AG (Germany), eClinicalWorks (US), Koninklijke Philips N.V. (Netherlands), and Veradigm (US).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 [email protected]